The Diagnostic Gap Has Not Been Solved: Gender, Race, and the Inequitable Distribution of Recognition

What the Evidence Tells Us About Who Gets Seen, Who Gets Believed, and Who Gets Helped

Part Three of an Ongoing Series on Adult ADHD and the Case for a New Clinical Framework

The first two articles in this series established what the research confirms: adult ADHD is a legitimate, persistent, and multi-domain clinical condition that demands comprehensive, integrated care (Bogdańska-Chomczyk et al., 2025; Cortese et al., 2025; Kooij, 2025). What neither article addressed directly is a more uncomfortable truth: access to recognition, diagnosis, and care is not equitably distributed. The diagnostic gap in adult ADHD is not randomly assigned. It follows the contours of gender and race with a consistency that the literature can no longer minimize.

THE GENDER GAP: STRUCTURAL, NOT BIOLOGICAL

Evidence increasingly suggests that women experience significant delays in ADHD recognition and diagnosis despite reporting comparable levels of functional impairment. Kooij (2025) notes that much of the historical ADHD literature was developed from predominantly male samples, contributing to diagnostic frameworks that are more sensitive to externalizing presentations than to the internalized, socially masked, and context-dependent presentations often reported by women. As a result, women frequently enter treatment after years of struggling with anxiety, depression, emotional dysregulation, relationship difficulties, or occupational impairment before ADHD is considered as a potential explanatory framework.

Kooij (2025), writing in World Psychiatry, identified this structural problem directly: not merely that women are underdiagnosed, but that the diagnostic criteria themselves were developed from research samples that systematically underrepresented female participants. The female presentation of ADHD tends to be internalized, socially masked, and highly context-dependent; quieter, less disruptive, and therefore less likely to prompt a referral or raise a clinical concern. What presents in a female client as chronic anxiety, emotional dysregulation, or difficulty sustaining relationships may be ADHD; what presents in a male client with identical neurobiological underpinnings may more readily be recognized as such.

Kooij et al. (2025), publishing in Frontiers in Global Women's Health, identified the role of hormonal transitions in intensifying ADHD symptoms across the female lifespan, particularly during premenstrual, postpartum, and perimenopausal phases. The authors highlight elevated rates of mood-related difficulties, including premenstrual dysphoric disorder and postpartum depression, as well as emerging evidence regarding cardiovascular health risks in midlife women with ADHD. These findings suggest that delayed recognition may contribute to a growing burden of secondary difficulties over time, underscoring the importance of earlier identification and appropriate support.

THE RACIAL GAP: A FAILURE OF RECOGNITION, NOT PREVALENCE

The diagnostic inequity extends beyond gender. Shalaby et al. (2024), in a large-scale analysis of 849,281 individuals diagnosed with ADHD and 157,597 individuals diagnosed with conduct disorder across 50 United States healthcare organizations, documented significant racial disparities in diagnostic patterns. Non-Hispanic White individuals were substantially more likely to receive an ADHD diagnosis than non-Hispanic Black individuals, while Black females represented the demographic least likely to receive an ADHD diagnosis among the groups examined. The authors also identified notable differences in age of diagnosis, suggesting that access to recognition and assessment may vary significantly across racial groups.

These disparities begin early and compound across the developmental span. Morgan et al. (2013), analyzing a nationally representative longitudinal sample from kindergarten through eighth grade, found that the odds of an ADHD diagnosis for African American children were 69% lower than for White children and 50% lower for Hispanic children, not because teacher reports documented lower frequencies of ADHD-related behavior, but because comparable behavioral concerns were less likely to result in an ADHD diagnosis.

Some researchers have described findings such as these as being consistent with a process of diagnostic substitution, in which similar behavioral presentations may be interpreted differently depending on the context in which they occur. Rather than being viewed through a neurodevelopmental framework that prompts ADHD assessment, certain presentations may be more likely to be conceptualized through a behavioral or conduct-oriented lens. While the mechanisms underlying these disparities remain an active area of investigation, the consequence may be delayed, missed, or misdirected pathways to care for some populations.

The predominantly inattentive presentation compounds this further. Individuals whose ADHD manifests not as disruption but as quiet, internal struggle—no outward behavior to flag, no referral generated—are disproportionately women and people of color. They are among the clients most likely to arrive in a counseling office in adulthood without a diagnostic framework that adequately explains their lifelong difficulties.

WHAT THE DIAGNOSTIC GAP ACTUALLY PRODUCES

The clinical consequences of these compounded inequities deserve explicit attention, because they are not merely administrative failures. Consider what it means to spend decades without a framework for one's own experience: to struggle persistently across school, work, and relationships, and to have no clinical explanation for why. In the absence of a diagnosis, people construct their own explanations, and those explanations are, with remarkable consistency, some version of personal failure. Not a condition with a name and a neurobiological basis, but a character indictment; lazy, undisciplined, too much, not enough.

Women who masked for decades. Adults of color who were misdiagnosed or never evaluated. Individuals whose quiet, inattentive presentation was never flagged. What these groups share is not merely a delayed diagnosis; they share a narrative, one built in the absence of accurate clinical information, shaped by repeated experiences of shame, underachievement, and self-blame. They did not receive a diagnosis. They received a story about who they are. And in many cases, that story was clinically inaccurate and deeply painful.

This is the territory in which meaning-making therapy begins: not symptom reduction, but the reconstruction of identity and self-understanding in the wake of a lifetime of misunderstanding, mislabeling, or unexplained struggle. That is precisely where this series is headed.

Stay tuned for Part Four, which begins building the theoretical and clinical case for meaning-making therapy as a framework uniquely suited to the adult ADHD population—and to the clients who have been waiting the longest to be seen.

Which population has your clinical experience revealed as most consistently underserved by current diagnostic frameworks—and what has been the cost, in human terms, of that gap? The conversation in the comments matters.

REFERENCES

Bogdańska-Chomczyk, E., Majewski, M. K., & Kozłowska, A. (2025). ADHD in adulthood: Clinical presentation, comorbidities, and treatment perspectives. International Journal of Molecular Sciences, 26(22), 11020. https://doi.org/10.3390/ijms262211020

Cortese, S., Bellgrove, M. A., Brikell, I., Franke, B., Goodman, D. W., Hartman, C. A., Larsson, H., Levin, F. R., Ostinelli, E. G., Parlatini, V., Ramos-Quiroga, J. A., Sibley, M. H., Tomlinson, A., Wilens, T. E., Wong, I. C. K., Hovén, N., Didier, J., Correll, C. U., Rohde, L. A., & Faraone, S. V. (2025). Attention-deficit/hyperactivity disorder (ADHD) in adults: Evidence base, uncertainties and controversies. World Psychiatry, 24(3), 347–371. https://doi.org/10.1002/wps.21374

Kooij, J. J. S. (2025). New developments and potential future research directions in adult ADHD. World Psychiatry, 24(3), 381–382. https://doi.org/10.1002/wps.21351

Kooij, J. J. S., de Jong, M., Agnew-Blais, J., Amoretti, S., Bang Madsen, K., Barclay, I., Bölte, S., Borg Skoglund, C., Broughton, T., Carucci, S., van Dijken, D. K. E., Ernst, J., French, B., Frick, M. A., Galera, C., Groenman, A. P., Kopp Kallner, H., Kerner auch Koerner, J., Kittel-Schneider, S., Manor, I., Martin, J., Matera, E., Parlatini, V., Philipsen, A., Ramos-Quiroga, J. A., Rapoport, I. L., Remnélius, K. L., Sénéquier, A., Thorell, L., Wittekoek, J. M. E., & Wynchank, D. (2025). Research advances and future directions in female ADHD: The lifelong interplay of hormonal fluctuations with mood, cognition, and disease. Frontiers in Global Women's Health, 6, 1613628. https://doi.org/10.3389/fgwh.2025.1613628

Morgan, P. L., Staff, J., Hillemeier, M. M., Farkas, G., & Maczuga, S. (2013). Racial and ethnic disparities in ADHD diagnosis from kindergarten to eighth grade. Pediatrics, 132(1), 85–93. https://doi.org/10.1542/peds.2012-2390

Shalaby, N., Sengupta, S., & Williams, J. B. (2024). Large-scale analysis reveals racial disparities in the prevalence of ADHD and conduct disorders. Scientific Reports, 14, 25123. https://doi.org/10.1038/s41598-024-75954-5